CPRX vs. CL
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPRX or CL.
Correlation
The correlation between CPRX and CL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CPRX vs. CL - Performance Comparison
Key characteristics
CPRX:
1.08
CL:
1.42
CPRX:
1.71
CL:
1.98
CPRX:
1.22
CL:
1.26
CPRX:
1.22
CL:
1.30
CPRX:
4.67
CL:
3.65
CPRX:
9.79%
CL:
5.90%
CPRX:
42.17%
CL:
15.15%
CPRX:
-94.25%
CL:
-58.91%
CPRX:
-10.32%
CL:
-14.15%
Fundamentals
CPRX:
$2.63B
CL:
$76.38B
CPRX:
$1.18
CL:
$3.48
CPRX:
18.70
CL:
26.86
CPRX:
0.00
CL:
2.11
CPRX:
$460.48M
CL:
$20.11B
CPRX:
$379.07M
CL:
$12.12B
CPRX:
$192.55M
CL:
$5.26B
Returns By Period
In the year-to-date period, CPRX achieves a 27.66% return, which is significantly higher than CL's 19.14% return. Over the past 10 years, CPRX has outperformed CL with an annualized return of 21.79%, while CL has yielded a comparatively lower 5.27% annualized return.
CPRX
27.66%
0.33%
41.37%
50.07%
41.49%
21.79%
CL
19.14%
-0.74%
-3.19%
22.78%
8.72%
5.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPRX vs. CL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CPRX vs. CL - Dividend Comparison
CPRX has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 2.13%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CL Colgate-Palmolive Company | 2.13% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% | 2.05% | 2.04% |
Drawdowns
CPRX vs. CL - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than CL's maximum drawdown of -58.91%. Use the drawdown chart below to compare losses from any high point for CPRX and CL. For additional features, visit the drawdowns tool.
Volatility
CPRX vs. CL - Volatility Comparison
Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 8.90% compared to Colgate-Palmolive Company (CL) at 4.24%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CPRX vs. CL - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities